Clinical Trial Update: Erlotinib and Everolimus in Treating Patients With Metastatic Breast Cancer [Phase 1]

View source ↗

Summary

Phase 1 study evaluating the combination of erlotinib and everolimus in metastatic breast cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• ERLOTINIB (Erlotinib)
• Everolimus (everolimus)

Snippet

Sponsor: Vanderbilt-Ingram Cancer Center | Conditions: Breast Cancer | Phase 1 | Status: COMPLETED